AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glynase-MF Tablet

Prescription Icon
Prescription Required

Marketer

USV Ltd

Salt Composition

Glipizide (5mg) + Metformin (500mg)

Overview Glynase-MF Tablet

DiaBeta-Duo tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. These tablets help regulate blood glucose in diabetic patients. DiaBeta-Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial, even with seemingly controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive treatment plan encompassing diet, exercise, and weight management as directed by your doctor; lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry readily available glucose (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Disclose any history of heart disease to your physician prior to use, as it may be unsuitable. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to check blood cell counts and liver function.

Primary Ingredients of Glynase-MF Tablet

The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.

Uses of Glynase-MF Tablet

Managing type 2 diabetes

Major Benefits of Glynase-MF Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. Glynase-MF tablets should be administered with meals.

Common Side effects of Glynase-MF Tablet:

  • Hypoglycemia (low blood glucose level)
  • Diarrhea
  • Headache
  • Upper respiratory tract infection

How to use Glynase-MF Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Glynase-MF Tablets should be administered with meals.

How Glynase-MF Tablet works:

Glipizide and metformin are combined in Glynase-MF tablets to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Glynase-MF tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glynase-MF tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glynase-MF tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glynase-MF tablets cautiously, potentially requiring dosage modifications. Severe kidney disease contraindicates Glynase-MF tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during Glynase-MF treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glynase-MF tablets cautiously, potentially requiring dose modification. Consultation with a physician is advised. For those with mild to moderate liver disease, Glynase-MF tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glynase-MF Tablet :

Should you forget a Glynase-MF Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glynase-MF Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glynase-MF Tablet

Glynase-MF tablets combine glipizide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glipizide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glynase-MF is not suitable for treating type 1 diabetes.
Glynase-MF Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Glynase-MF Tablets can cause hypoglycemia (low blood sugar), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always keep a readily available source of glucose, such as tablets, honey, or fruit juice, on hand.
Glynase-MF Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding Glynase-MF in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glynase-MF and seek immediate medical attention.
Prolonged Glynase-MF Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glynase-MF Tablets are contraindicated in patients allergic to any ingredient or excipient. They should also not be used by individuals with moderate to severe kidney disease or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glynase-MF tablets and alcohol is unsafe, as it risks dangerously low blood sugar (hypoglycemia) and raises the likelihood of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glynase-MF Tablet
18
MRP 20
11% off